BioLineRx Ltd. Increase Decrease Through Exercise Of Warrants Equity
BioLineRx Ltd. (BLRX) reported Increase Decrease Through Exercise Of Warrants Equity of $0 for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-23
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 |
| 2023-12-31 | $6.56M 20-F · filed 2026-03-23 |
| 2021-12-31 | $21.20M 20-F · filed 2024-03-26 |
| 2020-12-31 | $3.22M 20-F · filed 2023-03-22 |